Fundraising FoxMonograph Capital Partners — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
RQ Biorqbiotechnology.comJun 2026
RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease.
BiotechHealthtech
Co-investorsFrazier Life SciencesLifeArc VenturesOxford Science EnterprisesWellington ManagementEQT Life SciencesForbion+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.